D. Ribnikar, “Association between PIK3CA activating mutations and outcomes in early-stage invasive lobular breast carcinoma treated with adjuvant systemic therapy: PIK3CA activating mutations in invasive lobular breast carcinoma”, Radiol Oncol, vol. 57, no. 2, pp. 220–228, Jun. 2023.